Graph Database :: Data Schema

Graph Database :: Data Schema

×
Entries: ReferenceTherapeutic
Identifier Name
iuphar.ligand:9826 GSK1059615 [Guide to Pharmacology:9826]
pubchem.compound:11953153 Gemigliptin [PubChem Compound:11953153]
pubchem.substance:472419397 Gontivimab [PubChem Substance:472419397]
iuphar.ligand:9502 His-Leu-lopinavir [Guide to Pharmacology:9502]
kegg.compound:78435478 Hydroxychloroquine(2+) [COMPOUND:78435478]
iuphar.ligand:10733 I-432 [Guide to Pharmacology:10733]
iuphar.ligand:4960 IFN-α2 [Guide to Pharmacology:4960]
iuphar.ligand:8338 IFN-α2b (recombinant human) [Guide to Pharmacology:8338]
iuphar.ligand:8339 IFN-β1a (recombinant human) [Guide to Pharmacology:8339]
iuphar.ligand:8340 IFN-β1b (recombinant human) [Guide to Pharmacology:8340]
iuphar.ligand:8017 IM-12 [Guide to Pharmacology:8017]
iuphar.ligand:5691 KW-2449 [Guide to Pharmacology:5691]
iuphar.ligand:8030 L-739,750 [Guide to Pharmacology:8030]
pubchem.compound:216453 L-778123 [PubChem Compound:216453]
iuphar.ligand:8028 LB42908 [Guide to Pharmacology:8028]
iuphar.ligand:11236 LCB1 [Guide to Pharmacology:11236]
iuphar.ligand:11237 LCB3 [Guide to Pharmacology:11237]
iuphar.ligand:11167 LGK974 [Guide to Pharmacology:11167]
iuphar.ligand:6004 LY 294002 [Guide to Pharmacology:6004]
iuphar.ligand:7958 LY2090314 [Guide to Pharmacology:7958]
iuphar.ligand:8943 LY3009120 [Guide to Pharmacology:8943]
iuphar.ligand:5212 Li+ [Guide to Pharmacology:5212]
pubchem.compound:16656889 Linzagolix [PubChem Compound:16656889]
pubchem.compound:89658382 Lumicitabine [PubChem Compound:89658382]
iuphar.ligand:8601 MI-1148 [Guide to Pharmacology:8601]
iuphar.ligand:7945 MK-2206 [Guide to Pharmacology:7945]
iuphar.ligand:7962 MK-2461 [Guide to Pharmacology:7962]
iuphar.ligand:10346 MK-571 [Guide to Pharmacology:10346]
iuphar.ligand:9974 MK-8353 [Guide to Pharmacology:9974]
iuphar.ligand:10219 MP-A08 [Guide to Pharmacology:10219]
iuphar.ligand:5852 MRE-269 [Guide to Pharmacology:5852]
iuphar.ligand:8955 MS023 [Guide to Pharmacology:8955]
pubchem.substance:347910408 Methoxy polyethylene glycol-epoetin beta [PubChem Substance:347910408]
pubchem.compound:6476 Methsuximide [PubChem Compound:6476]
iuphar.ligand:4586 N-ethyl-1-deoxynojirimycin [Guide to Pharmacology:4586]
iuphar.ligand:316 N-methyl scopolamine [Guide to Pharmacology:316]
iuphar.ligand:481 NS-49 [Guide to Pharmacology:481]
iuphar.ligand:5714 NVP-TAE684 [Guide to Pharmacology:5714]
pubchem.substance:472418861 Nirsevimab [PubChem Substance:472418861]
iuphar.ligand:10507 OMO-1 [Guide to Pharmacology:10507]
iuphar.ligand:7935 PD 0325901 [Guide to Pharmacology:7935]
iuphar.ligand:5037 PD173074 [Guide to Pharmacology:5037]
iuphar.ligand:11250 PF-00835231 [Guide to Pharmacology:11250]
iuphar.ligand:10426 PF-06873600 [Guide to Pharmacology:10426]
iuphar.ligand:5700 PHA-665752 [Guide to Pharmacology:5700]
iuphar.ligand:5703 PLX-4720 [Guide to Pharmacology:5703]
pubchem.substance:472423423 Palivizumab [PubChem Substance:472423423]
pubchem.compound:45100481 Palmostatin B [PubChem Compound:45100481]
pubchem.compound:154575 Piclamilast [PubChem Compound:154575]
pubchem.compound:177358 Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)- (SP-4-3)-Amminedichloro(2-methylpyridine)platinium [PubChem Compound:177358]
iuphar.ligand:1771 R-138727 [Guide to Pharmacology:1771]
iuphar.ligand:5707 R547 [Guide to Pharmacology:5707]
iuphar.ligand:7744 RGB-286638 [Guide to Pharmacology:7744]
pubchem.compound:16719221 RO 5126766 [PubChem Compound:16719221]
iuphar.ligand:6625 ROMe [Guide to Pharmacology:6625]
Cite Us!